Valuation and consulting for financial reporting, federal, state and local tax, investment and risk management purposes.Valuation Advisory
The 2016 U.S. Goodwill Impairment Study by Duff & Phelps and the Financial Executives Research Foundation (FERF) examines general and industry goodwill impairment trends of 8,500+ U.S. publicly-traded companies, as well as an annual survey of FEI members that tracks the use of optional qualitative goodwill impairment test (a.k.a. “Step 0”) by its members.
Marianna Todorova, a managing director in Duff & Phelps’ Office of Professional Practice, discusses the Goodwill Impairment study and recent changes to impairment reporting proposed by the Financial Accounting Standards Board (FASB).
Read the full article here.
Duff & Phelps advised BioNTech AG on the collaboration deal with Pfizer
was acquired by
a portfolio company of
December 10-12, 2018 Washington, D.C.